secwatch / observer
8-K filed March 20, 2024, 7:59 PM ET CIK 0001628945
leadership confidence high sentiment neutral materiality 0.70

Cue Health CEO Ayub Khattak steps down; co-founder Clint Sever appointed CEO

Cue Health Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Clint Sever

Chief Executive Officer
Cue Health Inc.
Effective
2024-03-20
Filed
March 20, 2024, 7:59 PM ET
On March 20, 2024, the Company appointed co-founder and current Chief Product Officer, Clint Sever, as Chief Executive Officer.
Departed

Ayub Khattak

Chief Executive Officer, President and Chairman of the Board
Cue Health Inc.
Effective
2024-03-19
Successor
Clint Sever
Filed
March 20, 2024, 7:59 PM ET
On March 19, 2024, Cue Health Inc. (the “Company”) announced that Ayub Khattak is stepping down as Chief Executive Officer, President and Chairman of the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Clint Sever was appointed as Chief Executive Officer at Cue Health Inc..

Action
appointed
Role
Chief Executive Officer
Exact text from the filing
On March 20, 2024, the Company appointed co-founder and current Chief Product Officer, Clint Sever, as Chief Executive Officer.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Ayub Khattak departed as Chief Executive Officer, President and Chairman of the Board at Cue Health Inc..

Action
stepped down
Role
Chief Executive Officer, President and Chairman of the Board
Exact text from the filing
On March 19, 2024, Cue Health Inc. (the “Company”) announced that Ayub Khattak is stepping down as Chief Executive Officer, President and Chairman of the Board, effective immediately.
View on SEC.gov
Source: SEC EDGAR
accession 0001193125-24-072864
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.